Literature DB >> 9322513

Impaired intestinal sugar transport in cirrhotic rats: correction by low doses of insulin-like growth factor I.

I Castilla-Cortazar1, J Prieto, E Urdaneta, M Pascual, M Nuñez, E Zudaire, M Garcia, J Quiroga, S Santidrian.   

Abstract

BACKGROUND & AIMS: Malnutrition is a complication of liver cirrhosis accompanied by reduced insulin-like growth factor I (IGF-I) availability. The aim of this study was to analyze the effect of IGF-I on intestinal D-galactose absorption in cirrhotic rats.
METHODS: IGF-I (2 micrograms.100 g body wt-1.day-1) or saline were given for 14 days to rats in whom cirrhosis was induced with CCl4. Galactose transport and sodium-glucose/galactose-ligand transporter 1 (SGLT-1) expression were assessed in jejunal rings and in brush border membrane vesicles (BBMVs).
RESULTS: Compared with that in controls, galactose transport in everted jejunal rings was significantly reduced in cirrhotic rats but showed normal values after IGF-I treatment. The kinetic study of D-galactose uptake by BBMVs showed decreased maximal velocity (Vmax) and diminished transporter affinity in cirrhotic rats. These kinetic parameters reverted to normal after IGF-I treatment. Microvilli were significantly elongated in cirrhotic rats but of normal size in the IGF-I-treated group. The expression of SGLT-1 on BBMVs (Western blot) and on the luminal membrane of enterocytes (immunohistochemistry) was not reduced in cirrhotic animals compared with controls or IGF-treated cirrhotic rats.
CONCLUSIONS: Intestinal sugar transport is disturbed in experimental cirrhosis, and this alteration is corrected by IGF-I.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9322513     DOI: 10.1053/gast.1997.v113.pm9322513

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  22 in total

1.  IGF-I does not improve fat malabsorption in cirrhotic rats.

Authors:  R Pérez; I Castilla-Cortázar; M Núñez; A Prado; E Mirpuri; M García; S González Barón; A Picardi
Journal:  J Physiol Biochem       Date:  2001-03       Impact factor: 4.158

2.  Insulin-like growth factor I improves intestinal barrier function in cirrhotic rats.

Authors:  V Lorenzo-Zúñiga; C M Rodríguez-Ortigosa; R Bartolí; M-L Martínez-Chantar; L Martínez-Peralta; A Pardo; I Ojanguren; J Quiroga; R Planas; J Prieto
Journal:  Gut       Date:  2006-01-24       Impact factor: 23.059

3.  Effects of IGF-I treatment on osteopenia in rats with advanced liver cirrhosis.

Authors:  A Cemborain; I Castilla-Cortázar; M García; B Muguerza; G Delgado; M Díaz-Sánchez; A Picardi
Journal:  J Physiol Biochem       Date:  2000-06       Impact factor: 4.158

4.  IGF1 gene transfer into skeletal muscle using recombinant adeno-associated virus in a rat model of liver cirrhosis.

Authors:  M Zaratiegui; I Castilla-Cortázar; M García; J Quiroga; J Prieto; F J Novo
Journal:  J Physiol Biochem       Date:  2002-09       Impact factor: 4.158

5.  An experimental model of partial insulin-like growth factor-1 deficiency in mice.

Authors:  I Castilla-Cortazar; L Guerra; J E Puche; U Muñoz; R Barhoum; E Escudero; J L Lavandera
Journal:  J Physiol Biochem       Date:  2013-09-18       Impact factor: 4.158

6.  Hematotesticular barrier is altered from early stages of liver cirrhosis: effect of insulin-like growth factor 1.

Authors:  Inma Castilla-Cortazar; Nieves Diez; Maria Garcia-Fernandez; Juan-Enrique Puche; Fernando Diez-Caballero; Jorge Quiroga; Matias Diaz-Sanchez; Alberto Castilla; Amelia-Diaz Casares; Isabel Varela-Nieto; Jesus Prieto; Salvador Gonzalez-Baron
Journal:  World J Gastroenterol       Date:  2004-09-01       Impact factor: 5.742

7.  Mitochondrial protection by low doses of insulin-like growth factor- I in experimental cirrhosis.

Authors:  Raquel Pérez; María García-Fernández; Matías Díaz-Sánchez; Juan E Puche; Gloria Delgado; Marian Conchillo; Jordi Muntané; Inma Castilla-Cortázar
Journal:  World J Gastroenterol       Date:  2008-05-07       Impact factor: 5.742

8.  Rifaximin, but not growth factor 1, reduces brain edema in cirrhotic rats.

Authors:  Gemma Odena; Mireia Miquel; Anna Serafín; Amparo Galan; Rosa Morillas; Ramon Planas; Ramon Bartolí
Journal:  World J Gastroenterol       Date:  2012-05-07       Impact factor: 5.742

Review 9.  Changes of Intestinal Functions in Liver Cirrhosis.

Authors:  Hiroshi Fukui; Reiner Wiest
Journal:  Inflamm Intest Dis       Date:  2016-03-08

Review 10.  Human conditions of insulin-like growth factor-I (IGF-I) deficiency.

Authors:  Juan E Puche; Inma Castilla-Cortázar
Journal:  J Transl Med       Date:  2012-11-14       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.